Clinical Trials Logo

Clinical Trial Summary

To perform a clinical proof-of-concept study on a novel topical formula for pain relief.


Clinical Trial Description

An open-label study where each participant will be involved in the study for 4 weeks. During the study participants will use the topical cream 1-2 times daily on the anatomical area(s) causing the most pain. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05213052
Study type Interventional
Source Natural Immune Systems Inc
Contact
Status Completed
Phase N/A
Start date August 1, 2021
Completion date May 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Not yet recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Not yet recruiting NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Recruiting NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Not yet recruiting NCT05534126 - Enhancing Cognitive Processing Therapy for Posttraumatic Stress Disorder Via Stellate Ganglion Block Treatment: A Pilot Trial N/A
Not yet recruiting NCT05335486 - Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain Phase 2/Phase 3
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Active, not recruiting NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Active, not recruiting NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Not yet recruiting NCT05537662 - External Sensing and Neuromodulation to Assess Pain Comorbidity Outcomes (XANADU) N/A
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05457803 - Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and Pharmacology
Recruiting NCT05278533 - Evaluate the Use of the Foundation Pain Index and the Nutritional Supplement BioPleteā„¢ in Adults With Chronic Pain N/A
Completed NCT04546685 - Virtual Single-Session "Empowered Relief" Group Intervention for Chronic Pain N/A
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Recruiting NCT05036499 - PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain N/A